GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma

September 24, 2021 | Comments Off on GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma

World Journal of Clinical Oncology 2021 August 24 [Link] Javier Luna, Andrea Bobo, Joaquín José Cabrera-Rodriguez, María Pagola, Margarita Martín-Martín, María Ángeles González Ruiz, Miguel Montijano, Aurora Rodríguez, Lira Pelari-Mici,…

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment

September 23, 2021 | Comments Off on Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment

Journal of Clinical Medicine 2021 August 25 [Link] Vittorio Aprile, Alessandra Lenzini, Filippo Lococo, Diana Bacchin, Stylianos Korasidis, Maria Giovanna Mastromarino, Giovanni Guglielmi, Gerardo Palmiero, Marcello Carlo Ambrogi, Marco Lucchi…

Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status

September 22, 2021 | Comments Off on Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status

Modern Pathology 2021 September 8 [Link] Julia R Naso, Basile Tessier-Cloutier, Janine Senz, David G Huntsman, Andrew Churg Abstract p53 immunohistochemistry has long been proposed for the separation of benign…

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

September 21, 2021 | Comments Off on Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology 2021 September 6 [Link] Carmine Pinto, Paolo Andrea Zucali, Maria Pagano, Federica Grosso, Giulia Pasello, Marina Chiara Garassino, Marcello Tiseo, Hector Soto Parra, Francesco Grossi, Federico Cappuzzo,…

Management of Advanced Pleural Mesothelioma-At the Crossroads

September 20, 2021 | Comments Off on Management of Advanced Pleural Mesothelioma-At the Crossroads

JCO Oncology Practice 2021 September 7 [Link] Anna K Nowak, Alannah Jackson, Calvin Sidhu Abstract The management of pleural mesothelioma has changed with the demonstration that first-line checkpoint blockade therapy…

Profile of soluble factors in pleural effusions predict prognosis in mesothelioma

September 17, 2021 | Comments Off on Profile of soluble factors in pleural effusions predict prognosis in mesothelioma

Cancer Biomarkers 2021 August 24 [Link] I M Dick, Y C G Lee, H M Cheah, A Miranda, B W S Robinson, J Creaney Abstract Background: Pleural mesothelioma is a…

Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models

September 16, 2021 | Comments Off on Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models

Lung Cancer 2021 August 27 [Link] Helena Mumblat, Antonia Martinez-Conde, Ori Braten, Mijal Munster, Eyal Dor-On, Rosa S Schneiderman, Yaara Porat, Tali Voloshin, Shiri Davidi, Roni Blatt, Anna Shteingauz, Catherine…

Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology

September 15, 2021 | Comments Off on Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology

Cancer Cytopathology 2021 September 3 [Link] Ilaria Girolami, Ersilia Lucenteforte, Albino Eccher, Stefano Marletta, Matteo Brunelli, Paolo Graziano, Pasquale Pisapia, Umberto Malapelle, Giancarlo Troncone, Aldo Scarpa, Tao Huang, Liron Pantanowitz…

State of the art cytology of pleural fluid, focusing on the diagnosis of mesothelioma

September 14, 2021 | Comments Off on State of the art cytology of pleural fluid, focusing on the diagnosis of mesothelioma

Cytopathology 2021 September 1 [Link] Sara E Monaco, Luka Brcic, Sanja Dacic Abstract Objective: Mesothelioma has always been a challenging diagnosis to render in body cavity cytology samples. This review…

Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma

September 13, 2021 | Comments Off on Loss of Methylthioadenosine Phosphorylase by Immunohistochemistry Is Common in Pulmonary Sarcomatoid Carcinoma and Sarcomatoid Mesothelioma

American Journal of Clinical Pathology 2021 August 31 [Link] Simone Terra, Anja C Roden 1, Eunhee S Yi, Marie Christine Aubry, Jennifer M Boland Abstract Objectives: Differentiating malignant pleural mesothelioma…

Categories